Trump Drug-Price Push Spurs AstraZeneca CEO to Get Hustling (1)

When Pascal Soriot wants something done, he does it himself.

As AstraZeneca Plc met with the US administration multiple times ahead of an agreement on drug price cuts, there was one near-constant presence.

“I attended almost every single meeting,” the chief executive officer of the British drugmaker says. While Soriot spoke with President Donald Trump on a number of occasions, including at a state dinner at Windsor Castle, he also met with everyone from Commerce Secretary Howard Lutnick to Trade Representative Jamieson Greer. Perhaps most critical, according to the CEO, was getting buy-in from Mehmet Oz’s team at the ...